Effects of superovulation with oFSH and norgestomet/GnRH-controlled release of the LH surge on hormone concentrations, and yield of oocytes and embryos at specific developmental stages.
The objective of this study was to evaluate a new superovulation procedure with oFSH after temporary suppression of the endogenous LH surge by norgestomet followed by administration of GnRH, to collect bovine oocytes and embryos at specific developmental stages. Since 1999, our research group applies this superovulation procedure with controlled release of the endogenous LH surge. The objective of this study is to verify if this procedure is reliable for collection of oocytes and embryos at specific time points of development and if it produces a sufficient number of both oocytes and embryos of good quality. This procedure was validated regarding to hormonal characteristics, superovulatory response and both oocyte and embryo yield at different times of in vivo development. The results demonstrate that the procedure used to control the occurrence of the pre-ovulatory LH surge was effective in 92% of the animals (n = 238) and even in 99% of the animals the oocytes and embryos were collected at the intended stage of development. The superovulatory response and both oocyte, embryo yield and quality were similar to the average yield in Europe reported by Association Européenne de transfert embryonnaire (AETE). In conclusion, this superovulation procedure provides a valid tool to collect oocytes and embryos at specific time points of development.
Knijn
H M
HM
Department of Farm Animal Health, Utrecht University, CN Utrecht, The Netherlands. h.knijn@uu.nl
Fokker
W
W
van der Weijden
G C
GC
Dieleman
S J
SJ
Vos
P L A M
PL
D000818:Animals; D002417:Cattle / Q000196:embryology / Q000502:physiology*; D003692:Delayed-Action Preparations; D004958:Estradiol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D004973:Estrus Synchronization / Q000379:methods; D005260:Female; D005640:Follicle Stimulating Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D007315:Insemination, Artificial / Q000662:veterinary; D008297:Male; D009865:Oocytes / Q000502:physiology; D011282:Pregnenediones / Q000008:administration & dosage / Q000494:pharmacology*; D011461:Prostaglandins F, Synthetic / Q000008:administration & dosage / Q000494:pharmacology*; D012756:Sheep; D013480:Superovulation
D003692:Delayed-Action Preparations; D011282:Pregnenediones; D011461:Prostaglandins F, Synthetic; C100284:norgestomet; D004958:Estradiol; D005640:Follicle Stimulating Hormone; C049643:luprostenol